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Background: Chlorothalonil is a broad spectrum, non-systemic fungicide widely used to control
diseases affecting over 50 fruit, vegetable, and agricultural crops. Despite its extensive use for over 30
years, little is known about the potential human carcinogenicity associated with the routine application
of chlorothalonil. Rodent studies have shown evidence of renal tubular carcinomas and adenomas. We
explored cancer incidence with chlorothalonil exposure using data from the Agricultural Health Study, a
prospective cohort of licensed pesticide applicators in Iowa and North Carolina.
Methods: Licensed private and commercial pesticide applicators were recruited into this study from
1993 to 1997. Detailed information regarding pesticide use was obtained via self-administered
questionnaires. Cancer incidence was followed through December 31, 2004. Chlorothalonil exposure
was classiﬁed by lifetime exposure days and intensity-weighted lifetime exposure days, and then
categorized into tertiles. The intensity-weighted lifetime exposure days metric was calculated based on
a complex algorithm which includes pesticide application methods among other factors. This may
increase or decrease exposure.
Results: Of the 47,625 pesticide applicators included in this analysis, 3657 applicators reported using
chlorothalonil with a median of 3.5 application days per year. Chlorothalonil was not associated with
overall cancer incidence, nor did we ﬁnd any association with colon, lung, and prostate cancers—the
only cancers for which we had sufﬁcient numbers to explore associations.
Conclusion: We did not ﬁnd any strong evidence for an association between chlorothalonil and the
cancers investigated. Although animal studies have suggested renal cancer may be associated with
chlorothalonil, we had insufﬁcient data to evaluate this cancer.
Published by Elsevier Inc.

Keywords:
Chlorothalonil
Pesticides
Fungicides
Cancer
Agriculture

1. Introduction
Exposure to pesticides is recognized as an important environmental risk factor associated with the development of cancer
(Alavanja and Bonner, 2005; Miligi et al., 2006). Despite this
knowledge, there are insufﬁcient data on many commercially
available pesticides. The Agricultural Health Study (AHS) is a
prospective cohort study designed to evaluate both cancer
and non-cancer outcomes in pesticide applicators to better
understand risk factors for disease. Increased rates for certain
cancers among farmers such as leukemia, multiple myeloma, lip,
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prostate, and stomach have prompted several studies including
the AHS (Alavanja et al., 1996; Blair et al., 1992). Chlorothalonil
(2,4,5,6-tetrachloroisophthalonitrile), CAS number 1897-45-6, is a
broad spectrum, non-systemic pesticide that is used primarily as a
fungicide and mildewicide (US Environmental Protection Agency
(EPA), 1999; Wilkinson and Killeen, 1996). It has been widely used
to control diseases affecting more than 50 fruit, vegetable, and
agricultural crops and on turf, lawn, and ornamental plants
for over 30 years. The most popular uses of chlorothalonil in the
US include application to peanuts (about 34% of total chlorothalonil used in the US), potatoes (about 12%), tomatoes (about 7%),
and golf courses (about 10%) (US EPA, 1999). Because this
fungicide is non-systemic, it is often applied several times a
season to the same crop.
Chlorothalonil is resistant to hydrolysis, photolysis, and
volatilization. It is also persistent in water when microbial activity
is limited. It has been found to be practically or relatively non-toxic
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to avian species, small mammals, and honey bees; however,
chlorothalonil is highly toxic in amphibians, crustaceans, and ﬁsh
(US EPA, 1999). The mechanisms of action for chlorothalonil are
unknown, but some sources suggest that chlorothalonil is a multisite inhibitor affecting various enzymes and other metabolic
processes in fungi (Ministry of Agriculture Food and Fisheries of
British Columbia, 2004).
The US EPA has classiﬁed chlorothalonil as a probable
carcinogen (B2), based on sufﬁcient evidence of carcinogenicity
from animal studies but no epidemiologic data are available
(Orme and Kegley, 2006; US EPA, 1999). The International Agency
for Research on Cancers (IARC), on the other hand, has classiﬁed
chlorothalonil as a possible carcinogen (2B). The most recent
monograph (1999) indicates that there are no data available on
human carcinogenicity.
Studies in rodents have shown renal tubular adenomas and
carcinomas in male rats and mice and in female rats (IARC, 1999).
The metabolism of chlorothalonil in rats, by the action of
g-glutamyl transpeptidase and cysteine-conjugate b-lyase resulting in the production of di- and tri-thiols, is thought to be
responsible for the toxicity seen in the kidneys. These enzymes
may be less active in humans than in rats (IARC, 1999).
The limited data on chlorothalonil in humans, the reported
results of animal studies, and the widespread use of this pesticide
in agriculture in the United States prompted us to investigate
cancer incidence among pesticide applicators exposed to chlorothalonil in the AHS cohort.

2. Materials and methods
2.1. Cohort enrollment and follow-up
The AHS is a prospective cohort study of 57,311 applicators living in Iowa and
North Carolina who apply restricted-use pesticides. The participants were
recruited between 1993 and 1997 and include private applicators (primarily
farmers) and commercial applicators (employees of pest control companies or
businesses that use pesticides; from Iowa only). Farmers and commercial pesticide
applicators were identiﬁed when they sought restricted-use pesticide licenses
from their respective states. This cohort represented approximately 82% of eligible
applicators from both states during the enrollment period.
The cohort is linked annually with the state population-based cancer registries
in Iowa and North Carolina to assess incident cancer cases. Incident cancer cases
between enrollment and December 31, 2004 were identiﬁed among study
participants and reported using the International Classiﬁcation of Diseases for
Oncology, 2nd edition (ICD-O-2). Those cohort subjects who were alive but no
longer residing in Iowa or North Carolina were identiﬁed as no longer living in the
study area through current address records of the Internal Revenue Service, motor
vehicle registration ofﬁces, and pesticide license registries of the state agricultural
departments. Person-years accumulation for cancer incidence of individuals who
had moved from the state was censored in the year they departed. Less than 2% of
the cohort was lost to follow-up. The mean time of follow-up was 9.2 years. All
participants provided verbal informed consent, and the protocol was approved by
the institutional review boards of the National Cancer Institute, Batelle, the
University of Iowa, and Westat.

2.2. Exposure assessment
Exposure to chlorothalonil was assessed via a self-administered enrollment
questionnaire. Comprehensive exposure information, including days of use per
year and years of use, was obtained for chlorothalonil, along with 49 other
frequently used pesticides. Exposure to chlorothalonil was quantiﬁed using
information from this questionnaire. The questionnaire may be accessed at
http://aghealth.nci.nih.gov/questionnaires.html.
Two chlorothalonil exposure metrics were used in our analyses: lifetime
exposure days (LD) and intensity-weighted lifetime exposure days (IWLD).
To calculate LD we multiplied the number of application days per year by
the number of years of application. The IWLD metric was calculated by multiplying
the LD by an intensity score devised by an AHS industrial hygienist (M.D.)
and was calculated based on the following algorithm: intensity score ¼ (mixing
status+application method+equipment repair)  use of personal protective equipment (PPE) (Dosemeci et al., 2002).
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2.3. Statistical analysis
We carried out Poisson regression analyses to evaluate the risk of all cancers
combined and speciﬁc cancers with chlorothalonil exposure. Cancer sites were
selected for analysis if there were 5 or more incident cases of a given cancer for
each category of chlorothalonil-exposed subjects and 20 cases of the cancer
overall. Four cancer sites met these criteria—all cancers combined, colon, lung, and
prostate cancers. Although kidney cancer was the only cancer for which a priori
evidence of carcinogenic effects existed, we were unable to evaluate this cancer in
this analysis due to the low counts among exposed individuals (n ¼ 7).
Prevalent cancer cases identiﬁed at or prior to enrollment in this study were
excluded from these analyses. Additionally, 2430 applicators were excluded
because they did not provide complete information on chlorothalonil use
(i.e. missing data on ever/never use, use per year and number of years used),
which is required to accurately and consistently calculate the exposure metrics.
We included 47,625 applicators (43,968 non-exposed and 3657 exposed) in our
analysis.
Chlorothalonil exposure was categorized into tertiles for both LD and IWLD,
and comparisons were made to both the lowest exposed tertile and the nonexposed group. Potential confounders identiﬁed based on the literature and
biological plausibility included: age, smoking history, cancer history of ﬁrst-degree
relative, residence (Iowa or North Carolina), and applicator type (commercial or
private). We also considered other pesticides as potential confounders by
investigating the correlation coefﬁcients between chlorothalonil (IWLD) and all
49 other pesticides (IWLD) in the AHS. Highly correlated pesticides were identiﬁed
as those with a correlation coefﬁcient greater than 0.50 and are listed in Table 1.
However, when we included these pesticides in our models, they did
not signiﬁcantly change the rate ratios by more than 10%; therefore, we did
not include them in our ﬁnal models. Final models were adjusted for age
as a categorical variable (o40, 40–49, 50–59, X60), smoking history (never, low
o12 pack-years, highX12 pack-years), family history of cancer in ﬁrst-degree
relatives (yes/no), state of residence (Iowa or North Carolina), and applicator type
(private, commercial). Further adjustment for race, sex, education level, and
alcohol consumption did not change parameter estimates by more than 10% so we
did not include them in the ﬁnal models. Separate analyses were performed using
the non-exposed and lowest exposed groups as referent groups. P-values for trend
(p-trend) were calculated using chlorothalonil as a categorical variable, and all
statistical tests were two-sided.
All statistical analyses were conducted using Statas statistical software
program (release 9.0; Stata Corporation, College Station, Texas). We used the
P1REL0502 release of the AHS database.

3. Results
To determine the most appropriate reference group, we
evaluated selected characteristics of the chlorothalonil exposed
(lowest tertile and highest two tertiles) and non-exposed
applicators in the AHS cohort. These results are presented in
Table 1. The cohort was comprised primarily of white, male,
private applicators with relatively low smoking rates. Exposed and
non-exposed groups were similar with regard to age, gender, race,
alcohol consumption, and family history of cancer. Although the
lowest exposed tertile was more comparable to the highest two
tertiles with respect to residence (Iowa or North Carolina) and
education level, there was not a clear distinction as to which
group would be a more appropriate referent. As such, separate
analyses were performed using the non-exposed and lowest
exposed groups as the referent.
Table 2 displays adjusted rate ratios (RR) and conﬁdence
intervals (CI) for selected cancer sites with respect to chlorothalonil IWLD. As mentioned previously, we also carried out Poisson
regression analyses for the LD metric but only present results for
IWLD. For all cancers combined (n ¼ 2457), there was no
statistically signiﬁcant increased risk of cancer associated
with chlorothalonil exposure for comparison to the non-exposed
(highest tertile: RR ¼ 1.04, 95% CI ¼ 0.83–1.32) and the lowest
exposed (third tertile: RR ¼ 0.95, 95% CI ¼ 0.68–1.32) reference
groups. There were statistically signiﬁcant elevated RRs for
lung cancer when the non-exposed group was the reference
group in the second tertile of both IWLD (RR ¼ 1.95, 95%
CI ¼ 1.18–3.22; p-trend ¼ 0.19) and LD (RR ¼ 1.75, 95% CI ¼ 1.06–
2.90, p-trend ¼ 0.10). However, the association was diminished in
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Table 1
Characteristics of applicators by chlorothalonil exposure based on 1993–1997 enrollment data in the agricultural health study
Characteristics

Non-exposed group, no. (%)
(n ¼ 43,968)

Lowest exposed tertile, no. (%)
(n ¼ 1240)

Highest two tertiles, no. (%)
(n ¼ 2417)

Age
o40
40–49
50–59
X60

15,017
12,654
8997
7300

Racea
White
Other

43,199 (98.4%)
692 (1.6%)

1165 (94.0%)
74 (6.0%)

2270 (94.0%)
146 (6.0%)

Sex
Male
Female

42,838 (97.4%)
1,130 (2.6%)

1174 (94.7%)
66 (5.3%)

2349 (97.2%)
68 (2.8%)

State of Residence
Iowa
North Carolina

32,373 (73.6%)
11,595 (26.4%)

357 (28.8%)
883 (71.2%)

338 (14.0%)
2079 (86.0%)

Educational levela
High school/GED or less
Beyond high school

23,933 (55.5%)
19,223 (44.5%)

578 (48.2%)
621 (51.8%)

1141 (48.5%)
1213 (51.5%)

Applicator typeb
Commercial
Private

4127 (9.4%)
39,841 (90.6%)

145 (11.7%)
1095 (88.3%)

238 (9.8%)
2179 (90.2%)

Smoking history
Never
Low (o12 pack-yrs)
High (Z12 pack-yrs)

24,517 (55.8%)
9944 (22.6%)
9507 (21.6%)

566 (45.6%)
337 (27.2%)
337 (27.2%)

1144 (55.1%)
564 (22.8%)
709 (29.3%)

Current alcohol consumptiona
Never
Ever

13,019 (29.8%)
30,729 (70.2%)

493 (40.0%)
740 (60.0%)

917 (38.2%)
1484 (61.8%)

Family history of cancer in ﬁrst-degree relatives
No
26,359 (60.0%)
Yes
17,609 (40.0%)

764 (61.6%)
476 (38.4%)

1467 (60.7%)
950 (40.0%)

Use of highly correlated pesticides (ever use)
Dieldrin
682 (3.5%)
Heptachlor
2349 (12.2%)
Ziram
66 (0.3%)

30 (5.6%)
57 (10.6%)
10 (1.9%)

21 (2.2%)
32 (3.3%)
21 (2.2%)

a
b

(34.2%)
(28.8%)
(20.5%)
(16.6%)

483
314
214
229

(39.0%)
(25.3%)
(17.3%)
(18.5%)

906
711
420
380

(37.5%)
(29.4%)
(17.4%)
(15.7%)

Values do not equal the totals (n) due to missing values.
‘‘Private applicators’’ refers primarily to individual farmers and ‘‘Commercial applicators’’ refers to professional pesticide applicators.

the highest tertiles for each exposure metric, and tests for
trend were not statistically signiﬁcant. For all other cancers
investigated, no elevated risks were found for comparison to
either reference group. The results for lifetime days were similar
(data not shown).
Because chlorothalonil is a fungicide, the average number of
days of application per year are few (median of 3.5 days; range:
0.5–25 days), thus the lifetime days metric is weighted more by
years of use than frequency of use (days per year). To assess
whether frequency of use was a better exposure metric, we ran an
additional analysis based on the days of use (average days
applied/year). The results for this analysis were similar for LD
and for those presented in Table 2 for IWLD.
Additionally, we repeated our analyses for the selected cancer
sites, restricting the data to applicators in North Carolina only
(data not shown) because chlorothalonil use was uncommon in
Iowa. The results were similar to those presented in Table 2.

4. Discussion
In this study, we evaluated the association between cancer
incidence and chlorothalonil exposure using a number of
exposure metrics (LD, IWLD, and average days/year). None of

these metrics provided evidence for an association between
chlorothalonil and the four cancer sites analyzed. Although RRs
for lung cancer were elevated in the second tertile of IWLD when
the reference group was the non-exposed applicators, the RRs for
the third tertiles were not elevated, and tests for trend were not
statistically signiﬁcant.
This study has several major strengths. The large, prospective
design of the AHS separates this from other pesticide-related
studies. Exposure information was collected prior to cancer
diagnosis which minimized recall bias, and the comprehensive
questionnaire data enabled us to categorize chlorothalonil
exposure into tertiles, providing greater discrimination between
high and low exposures. In general, farmers provide accurate and
reliable information regarding their pesticide use (Blair et al.,
2002; Hoppin et al., 2002). Additionally, detailed information on
the use of many common pesticides and lifestyle characteristics
allowed us to adjust for potential confounding factors. Case
identiﬁcation through cancer registries provides a consistency in
the outcome measures.
Limitations of this study include the relatively small number of
incident cases of cancer in the chlorothalonil exposed population
(n ¼ 4375), thus precluding our ability to evaluate less common
and potentially relevant cancer sites (e.g. kidney cancer). As
mentioned previously, the most recent IARC monograph for
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Table 2
Rate ratiosa for selected cancers through December 2004 by intensity-weighted lifetime exposure days (IWLD)b of exposure to chlorothalonilc among agricultural health
study cohort applicators
Cancer Site

IWLD Exposure

Cases (n)

Non-exposed referent
RR

Lowest exposed referent
95% CI

RR

95% CI

p-trendd
All cancer

Colon

Lung

Prostate

p-trendd

No exposure
o70
70–368
4368

2457
75
77
78

1.00 (referent)
1.13
1.11
1.04

No exposure
o70
70–368
4368

187
7
5
8

p-trend ¼ 0.36
1.00 (referent)
1.41
0.65–3.02
0.97
0.39–2.40
1.46
0.70–3.03

No exposure
o70
70–368
4368

226
11
17
10

p-trend ¼ 0.31
1.00 (referent)
1.37
0.74–2.52
1.95
1.18–3.22
0.96
0.51–1.83

No exposure
o70
70–368
4368

1038
32
26
23

p-trend ¼ 0.19
1.00 (referent)
1.21
0.85–1.74
0.97
0.65–1.44
0.79
0.52–1.21

0.90–1.43
0.88–1.39
0.83–1.32

p-trend ¼ 0.47

1.00 (referent)
1.00
0.95

0.72–1.38
0.68–1.32

p-trend ¼ 0.75
1.00 (referent)
0.77
1.16

0.24–2.48
0.39–3.41

p-trend ¼ 0.77
1.00 (referent)
1.41
0.72

0.66–3.02
0.30–1.72

p-trend ¼ 0.46
1.00 (referent)
0.81
0.65

0.48–1.37
0.37–1.12

p-trend ¼ 0.12

a

RR adjusted for age, smoking history, family history of cancer in ﬁrst-degree relative, state of residence, and applicator type.
IWLD ¼ years of use  number of days of use each year  intensity score.
c
Total number exposed to chlorothalonil included in this regression analysis ¼ 2557.
d
p-Values are two sided.
b

chlorothalonil indicated a lack of human carcinogenic data
(IARC, 1999). To our knowledge, this is the ﬁrst study to use a
prospective, population-based sample to evaluate cancer risk and
chlorothalonil exposure. Although the number of exposed cases
was somewhat limited by the relatively short follow-up time, the
prospective design and on-going data collection will allow further
analyses as more cases occur.
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